Abstract
Objective The subjective experiences were assessed of cochlear implant (CI) users either wearing or not wearing a hearing aid (HA) at the contralateral ear.
Design Unilateral CI-recipients were asked to fill out a set of daily-life questionnaires on bimodal HA use, hearing disability, hearing handicap and general quality of life.
Study sample Twenty-six CI-recipients who regularly use a contralateral HA (bimodal group) and twenty-two CI-recipients who do not use a HA in the contralateral ear (unilateral group).
Results Comparisons between both groups (bimodal versus unilateral) showed no difference in self-rated disability, hearing handicap or general quality of life. However within the group of bimodal listeners, participants did report a significant benefit of bimodal hearing ability in various daily life listening situations.
Conclusions Bimodal benefit in daily life can consistently be experienced and reported within the group of bimodal users.
Competing Interest Statement
A research grant from Advanced Bionics Inc. to MUMC+ financially supported the work of the first author (E.D.) in this investigator-initiated study. The second author (M.J.) reviewed the manuscript and provided statistical support, made possible by a grant from the Dutch Heinsius-Houbolt Foundation. The third author (J.C.) holds a scientific post in the Advanced Bionics European Research Center. For the remaining authors no conflicts were declared. The study was designed in cooperation between MUMC+ and Advanced Bionics. Data collection, analysis and the decision to publish were all solely accounted for by MUMC+. The work presented in this manuscript is the intellectual property of MUMC+.
Clinical Trial
This study is part of a larger clinical trial registered in the Dutch National Trial Register (NTR3932).
Funding Statement
A research grant from Advanced Bionics Inc. to MUMC+ financially supported the work of the first author (E.D.). The statistical support by the second author (M.J.) was made possible by a grant from the Dutch Heinsius-Houbolt Foundation. The third author (J.C.) holds a scientific post in the Advanced Bionics European Research Center.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are fully available without restriction. All relevant data are within the paper.
